To determine how these treatments might functionally change CD8+ T cells in the tumor microenvironment, we performed gene set enrichment analysis (GSEA) of all CD8+ T cells and evaluated differentially expressed genes between the control group and each treatment group. This evidence concerns the gene CD8A and neoplasm.